MTNR1B: A Melatonin Receptor (G4544)

Target Name: MTNR1B

NCBI ID: G4544

MTNR1B

MTNR1B: A Melatonin Receptor

Melatonin is a molecule that plays a crucial role in regulating sleep-wake cycles and many other physiological processes in the body. It is produced by the pineal gland, which is located in the brain, and is released at the beginning of the night to help people fall asleep. Melatonin has been shown to have a wide range of effects on the body, including regulating the production of hormones, controlling blood pressure, and protecting against infection.

One of the many different types of melatonin receptors is the melatonin receptor type 1B (MTNR1B). This receptor is found on the surface of many different tissues in the body, including the brain, heart, and lungs. It is thought to play a key role in regulating the effects of melatonin, and may be a drug target or biomarker for several different diseases.

The MTNR1B receptor is a G protein-coupled receptor, which means that it is a protein that is linked to a specific protein called G protein-coupled receptor (GPCR). This protein is responsible for transmitting signals from the MTNR1B receptor to other cells in the body.

One of the ways that MTNR1B may be involved in the regulation of sleep-wake cycles is by controlling the production of hormones that are involved in the production of wakefulness. For example, studies have shown that MTNR1B is involved in the production of adenosine, a hormone that helps to promote wakefulness. Adenosine production is increased in the body at the end of the day and is thought to be a key factor in promoting sleep-wake cycles.

MTNR1B may also be involved in the regulation of blood pressure, as studies have shown that it is involved in the production of nitric oxide, a molecule that helps to relax blood vessels and lower blood pressure. This can have important implications for the treatment of hypertension, as hypertension is a leading cause of heart disease.

In addition to its potential role in the regulation of sleep-wake cycles and blood pressure, MTNR1B may also be involved in the regulation of other physiological processes in the body. For example, studies have shown that MTNR1B is involved in the production of other hormones, such as melatonin itself, and that it is involved in the regulation of immune function.

Given its involvement in a wide range of physiological processes, it is not surprising that MTNR1B has been identified as a potential drug target or biomarker. Researchers are currently working to develop new treatments for diseases that are related to MTNR1B, including hypertension, heart disease, and immune dysfunction.

In conclusion, MTNR1B is a melatonin receptor that is found on the surface of many different tissues in the body. It is thought to play a key role in regulating the effects of melatonin, and may be a drug target or biomarker for several different diseases. Further research is needed to fully understand the role of MTNR1B in the regulation of sleep-wake cycles and other physiological processes in the body.

Protein Name: Melatonin Receptor 1B

Functions: High affinity receptor for melatonin. Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity

The "MTNR1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTNR1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets